Menu
Back to Journals » Lung Cancer: Targets and Therapy » Volume 10
Review
Profile of entrectinib and its potential in the treatment of ROS1-positive NSCLC: evidence to date
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 11,054 | Dovepress* | 6,865+ | 1,275 | 8,140 | |
| PubMed Central* | 4,189 | 674 | 4,863 | ||
| Totals | 11,054 | 1,949 | 13,003 | ||
| *Since 9 September 2019 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 1 | 0 | 1 |
View citations on PubMed Central and Google Scholar